悠等生2018
2020-12-21
这篇文章不错,转发给大家看
@艾达财经:
【第39期:分析ARKG! 新建仓了一只新上市的医疗股:MASS!】本周重点介绍了遗传领域的创新基金,ARKG,发现基金本周频繁操作医疗类股票,所以引起关注。 二是重点介绍了增持的5只股票,薛定谔,SDGR, 诺华制药,NVS,爱奥尼斯制药,IONS, 武田制药,TAK和表面肿瘤学,SURF,此外还新建仓一只新股,MASS。
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP,发表看法
APP内打开
发表看法
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":330176415,"tweetId":"330176415","gmtCreate":1608563712837,"gmtModify":1703735475654,"author":{"id":3458337590868714,"authorId":3458337590868714,"authorIdStr":"3458337590868714","name":"悠等生2018","avatar":"https://static.tigerbbs.com/4082aa1f767467932e6865cc9e238ee2","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":14,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body>\n这篇文章不错,转发给大家看</body></html>","htmlText":"<html><head></head><body>\n这篇文章不错,转发给大家看</body></html>","text":"这篇文章不错,转发给大家看","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/330176415","repostId":330393975,"repostType":1,"repost":{"magic":2,"id":330393975,"tweetId":"330393975","gmtCreate":1608534160093,"gmtModify":1703735215565,"author":{"id":3570625982426607,"authorId":3570625982426607,"authorIdStr":"3570625982426607","name":"艾达财经","avatar":"https://static.tigerbbs.com/cc7b129b0b3f9754d63a848f85e11dfd","vip":8,"userType":8,"introduction":"专注方舟基金ARKK,ARKW,ARKG等美股分析","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":4243,"starInvestorFlag":false},"themes":[{"themeId":"258552fe880d444a8ceedf02b1969a86","categoryId":"bc7f9e79615545918dda2e7d7cfb9e15","name":"追踪ARK女神","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":258552fe880d444a8ceedf02b1969a86}&rnconfig={\"headerBarHidden\": true}","description":"Catherine Wood于2013年创办方舟投资管理公司。她的投资绩效非常突出,一起追踪ARK持仓~","image":"https://static.tigerbbs.com/a9e2e5103e0734663e9364cb0c8fe152"}],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>【第39期:分析ARKG! 新建仓了一只新上市的医疗股:MASS!】本周重点介绍了遗传领域的创新基金,ARKG,发现基金本周频繁操作医疗类股票,所以引起关注。 二是重点介绍了增持的5只股票,薛定谔,SDGR, 诺华制药,NVS,爱奥尼斯制药,IONS, 武田制药,TAK和表面肿瘤学,SURF,此外还新建仓一只新股,MASS。</p></body></html>","htmlText":"<html><head></head><body><p>【第39期:分析ARKG! 新建仓了一只新上市的医疗股:MASS!】本周重点介绍了遗传领域的创新基金,ARKG,发现基金本周频繁操作医疗类股票,所以引起关注。 二是重点介绍了增持的5只股票,薛定谔,SDGR, 诺华制药,NVS,爱奥尼斯制药,IONS, 武田制药,TAK和表面肿瘤学,SURF,此外还新建仓一只新股,MASS。</p></body></html>","text":"【第39期:分析ARKG! 新建仓了一只新上市的医疗股:MASS!】本周重点介绍了遗传领域的创新基金,ARKG,发现基金本周频繁操作医疗类股票,所以引起关注。 二是重点介绍了增持的5只股票,薛定谔,SDGR, 诺华制药,NVS,爱奥尼斯制药,IONS, 武田制药,TAK和表面肿瘤学,SURF,此外还新建仓一只新股,MASS。","highlighted":1,"essential":2,"paper":1,"link":"https://laohu8.com/post/330393975","repostId":0,"isVote":1,"tweetType":2,"object":{"id":"99a056131eb244daab512d648d83efd9","videoUrl":"https://1254107296.vod2.myqcloud.com/73ba5544vodgzp1254107296/e44074d05285890811547357751/FV6gXQEFHhEA.mp4","poster":"https://static.tigerbbs.com/1761a15d09ed2ec2850c155e7cfcc103","desc":""},"commentLimit":10,"symbols":["IONS","SURF","NVS","SDGR"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":259,"xxTargetLangEnum":"ZH_CN"},"isVote":1,"tweetType":1,"viewCount":985,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":25,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/330176415"}
精彩评论